NervGen Pharma Corp. Common stock
$1.59
-0.03 (-1.85%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -30.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -33.0%
Own NGEN?
See how NGEN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.